Source: https://www.google.nl/patents/US6720001
Timestamp: 2018-01-18 23:19:06
Document Index: 234002921

Matched Legal Cases: ['art 1989', 'art 1992', 'art 1993', 'art 1995', 'art 1996', 'art 1995', 'art 1994', 'art 1998', 'art 1989', 'art 2004', 'art 2004', 'art 2010', 'art 2011', 'art 2005', 'art 2012', 'art 2012', 'art 2013', 'art 2013', 'art 2013', 'art 2007', 'art 2015', 'art 2015', 'art 2015', 'art 2015', 'art 2016', 'art 2013', 'art 2013', 'art 2017', 'art 2014', 'art 2015', 'art 2016', 'art 2004', 'art 2005', 'art 2004', 'art 2006', 'art 2006', 'art 2007', 'art 2007', 'art 2007', 'art 2007', 'art 2006', 'art 2008', 'art 2008', 'art 2007', 'art 2009', 'art 2009', 'art 2010', 'art 2010', 'art 2009', 'art 2011', 'art 2015', 'art 2011', 'art 2013']

Patent US6720001 - Emulsion compositions for polyfunctional active ingredients - Google Patenten
The present invention provides pharmaceutical oil-in-water emulsions for delivery of polyfunctional active ingredients. The emulsions include an aqueous phase, an emulsifier, and an oil phase, wherein the oil phase includes a structured triglyceride that is substantially free of triglycerides having...https://www.google.nl/patents/US6720001?utm_source=gb-gplus-sharePatent US6720001 - Emulsion compositions for polyfunctional active ingredients
Publicatienummer US6720001 B2
Aanvraagnummer US 09/420,159
Publicatiedatum 13 april 2004
Aanvraagdatum 18 okt 1999
Prioriteitsdatum 18 okt 1999
Ook gepubliceerd als US20020107265, WO2001028555A1
Publicatienummer 09420159, 420159, US 6720001 B2, US 6720001B2, US-B2-6720001, US6720001 B2, US6720001B2
Uitvinders Feng-Jing Chen, Mahesh V. Patel
Oorspronkelijke patenteigenaar Lipocine, Inc.
Patentcitaties (41), Niet-patentcitaties (3), Verwijzingen naar dit patent (276), Classificaties (14), Juridische gebeurtenissen (8)
US 6720001 B2
US4711902 18 okt 1984 8 dec 1987 Bayer Aktiengesellschaft Medicament formulation
US4719239 22 feb 1985 12 jan 1988 Muller Bernd W W Pharmaceutical multicomponent systems and method of preparing same
US4753963 * 26 sept 1985 28 juni 1988 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
US4816247 11 sept 1985 28 maart 1989 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
US4871768 * 3 sept 1987 3 okt 1989 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US4990337 12 april 1990 5 feb 1991 Sankyo Company Limited Cyclosporin formulations of mono or diglyceride fatty acid
US5098606 6 nov 1990 24 maart 1992 Shiseido Company Ltd. Emulsified composition
US5364632 9 maart 1993 15 nov 1994 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
US5407683 1 okt 1992 18 april 1995 Research Corporation Technologies, Inc. Pharmaceutical solutions and emulsions containing taxol
US5527537 12 mei 1993 18 juni 1996 Dietl; Hans Pharmaceutical preparation containing cyclosporine(s) for intravenous administration and a process for its production
US5534261 * 17 jan 1995 9 juli 1996 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US5616330 19 juli 1994 1 april 1997 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US5616332 * 27 maart 1995 1 april 1997 Herstein; Morris Cosmetic skin-renewal-stimulating composition with long-term irritation control
US5616342 11 april 1995 1 april 1997 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5622714 28 maart 1996 22 april 1997 Dietl; Hans Pharmaceutical preparation containing cyclosporine(s) for intravenous administration and process for its production
US5660858 3 april 1996 26 aug 1997 Research Triangle Pharmaceuticals Cyclosporin emulsions
US5661180 * 30 maart 1995 26 aug 1997 Abbott Laboratories Structured lipid containing gama-linolenic or dihogamma-linolenic fatty acid residue, a medium chain (C6 -C12) fatty acid residue, and a n-3 fatty acid residue
US5681855 19 maart 1994 28 okt 1997 Schwarz Pharma Ag PGE1 emulsion composition kit
US5693337 10 juli 1995 2 dec 1997 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
US5698593 * 15 april 1993 16 dec 1997 The United States Of America As Represented By The Department Of Health And Human Services Method for treating acne
US5731355 18 feb 1997 24 maart 1998 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US5780676 * 7 juni 1995 14 juli 1998 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US6030374 * 29 mei 1998 29 feb 2000 Mcdaniel; David H. Ultrasound enhancement of percutaneous drug absorption
US6130244 * 25 feb 1998 10 okt 2000 Abbott Laboratories Product and method to reduce stress induced immune suppression
US6160007 * 1 sept 1999 12 dec 2000 Abbott Laboratories Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
US6267985 * 30 juni 1999 31 juli 2001 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192 * 26 feb 1999 25 sept 2001 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6309663 * 17 aug 1999 30 okt 2001 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US6316497 * 5 juni 2001 13 nov 2001 Abbott Laboratories Self-emulsifying systems containing anticancer medicament
US6320074 * 27 okt 1998 20 nov 2001 Ligand Pharmaceuticals Incorporated Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US6333999 * 6 nov 1998 25 dec 2001 International Business Machines Corporation Systematic enumerating of strings using patterns and rules
US6339107 * 2 aug 2000 15 jan 2002 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
US6451339 * 2 juli 2001 17 sept 2002 Lipocine, Inc. Compositions and methods for improved delivery of hydrophobic agents
US20010025046 * 24 juni 1999 27 sept 2001 Rong(Ron) Liu Self-emulsifying systems containing anticancer medicament
US20030133974 * 5 dec 2002 17 juli 2003 Curatolo William John Encapsulated solution dosage forms of sertraline
WO1989002275A1 * 31 aug 1988 23 maart 1989 New England Deaconess Hospital Corporation Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
WO1994008603A1 * 15 okt 1993 28 april 1994 Smithkline Beecham Corporation Compositions
WO1995031110A1 * 11 mei 1995 23 nov 1995 American Home Products Corporation Corandomized fat compositions for infant formulas
WO1997025977A1 * 20 jan 1997 24 juli 1997 Novartis Ag Pharmaceutical compositions
1 Babayan, V.K., "Medium Chain Triglycerides and Structured Lipids," Specialty Lipids and Their Biofunctionality Symposium, LIPIDS, vol. 22, No. 6 (1987).
2 * Lucero et al., Therapeutic efficacy . . . , abstract, Internationak Journal of Pharmaceutics, 1996, vol. 127(1), pp. 73-83.*
3 www.rxmed.com/monographs/diazem.html, publication date unknown.
US7033998 11 april 2003 25 april 2006 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7323206 4 maart 2004 29 jan 2008 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US7405203 4 mei 2007 29 juli 2008 Reprise Biopharmaceutics, Llc Pharmaceutical compositions including low dosages of desmopressin
US7431986 * 24 juli 2002 7 okt 2008 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
US7468428 17 maart 2004 23 dec 2008 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7541384 3 okt 2008 2 juni 2009 Axcan Pharma Inc. Mesalamine suppository
US7560429 7 mei 2003 14 juli 2009 Ferring B.V. Orodispersible dosage forms of desmopressin acetate
US7579321 15 juli 2008 25 aug 2009 Reprise Biopharmaceutics, Llc Pharmaceutical compositions including low dosages of desmopressin
US7605122 31 juli 2006 20 okt 2009 Millennium Medical Spa Human chorionic gonadotropin (hCG) formulations for facilitating weight loss and body contouring
US7655252 25 juni 2002 2 feb 2010 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US7682628 3 aug 2007 23 maart 2010 Transcept Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US7700588 13 jan 2005 20 april 2010 Merkus Franciscus Wilhelmus He Pharmaceutical compositions comprising midazolam in a high concentration
US7740875 8 okt 2004 22 juni 2010 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7745400 11 okt 2006 29 juni 2010 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US7763663 19 dec 2002 27 juli 2010 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
US7767216 29 dec 2000 3 aug 2010 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US7776349 11 okt 2005 17 aug 2010 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7799761 12 nov 2003 21 sept 2010 Allergan, Inc. Pharmaceutical compositions including low dosages of desmopressin
US7803413 31 okt 2005 28 sept 2010 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
US7803414 8 aug 2006 28 sept 2010 General Mills Ip Holdings Ii, Llc Encapsulation of readily oxidizable components
US7871632 * 12 juli 2004 18 jan 2011 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US7914801 8 juli 2004 29 maart 2011 The United States Of America As Represented By The Secretary Of Agriculture Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations
US7947654 18 juni 2009 24 mei 2011 Ferring B.V. Pharmaceutical formulations
US7947741 16 maart 2005 24 mei 2011 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
US8026250 10 dec 2010 27 sept 2011 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8026281 22 april 2005 27 sept 2011 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate
US8142831 27 sept 2010 27 maart 2012 General Mills Ip Holdings Ii, Llc Encapsulation of readily oxidizable components
US8143225 15 juli 2008 27 maart 2012 Allergan, Inc. Pharmaceutical compositions including low dosages of desmopressin
US8217083 1 juni 2009 10 juli 2012 Aptalis Pharma Canada Inc. Mesalamine suppository
US8222268 17 aug 2011 17 juli 2012 Adventrx Pharmaceuticals, Inc. Methods for reducing vein irritation
US8226977 2 juni 2005 24 juli 2012 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
US8242131 23 mei 2006 14 aug 2012 Transcept Pharmaceuticals, Inc. Methods of treating middle-of-the-night insomnia
US8246977 21 okt 2005 21 aug 2012 Durect Corporation Transdermal delivery systems
US8252319 31 juli 2007 28 aug 2012 Durect Corporation Transdermal delivery system for sufentanil
US8252320 31 juli 2007 28 aug 2012 Durect Corporation Transdermal delivery system for sufentanil
US8252326 1 juni 2005 28 aug 2012 Catalent Australia Pty Ltd. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
US8252809 8 juni 2010 28 aug 2012 Transcept Pharmaceuticals, Inc. Compositions for treating insomnia
US8263581 11 feb 2010 11 sept 2012 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8314083 2 juli 2010 20 nov 2012 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8343974 9 juli 2010 1 jan 2013 Scott Iii Linzy O Methods and compositions for treating thyroid-related medical conditions with reduced folates
US8343995 26 april 2008 1 jan 2013 Cydex Pharmaceuticals, Inc. Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
US8399410 6 aug 2008 19 maart 2013 Allergan, Inc. Methods and devices for desmopressin drug delivery
US8404645 * 11 sept 2008 26 maart 2013 Novo Nordisk As Stable formulations of amylin and its analogues
US8414920 31 mei 2012 9 april 2013 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
US8436051 16 dec 2009 7 mei 2013 Aptalis Pharma Canada Inc. Mesalamine suppository
US8470304 4 aug 2009 25 juni 2013 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use
US8476252 * 25 april 2011 2 juli 2013 Besins Healthcare Luxembourg Sarl Pharmaceutical emulsion compositions comprising progestogen
US8501174 28 juni 2010 6 aug 2013 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US8513259 21 sept 2011 20 aug 2013 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8530436 29 jan 2007 10 sept 2013 Transderm, Inc. Methods and compositions for transdermal delivery of nucleotides
US8569357 18 feb 2011 29 okt 2013 Teikoku Pharma Usa, Inc. Taxane pro-emulsion formulations and methods making and using the same
US8574622 30 juli 2011 5 nov 2013 M & P Patent Aktiengesellschaft Controlled release delivery system for nasal applications
US8575171 28 nov 2012 5 nov 2013 Linzy O. Scott, III Methods and compositions for treating thyroid-related medical conditions with reduced folates
US8603568 14 jan 2011 10 dec 2013 Kemin Industries, Inc. Hydrolyzed lecithin product to improve digestibility
US8703164 31 okt 2007 22 april 2014 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US8709387 13 mei 2013 29 april 2014 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use
US8765149 * 25 april 2011 1 juli 2014 Besins Healthcare Luxembourg Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
US8765811 15 maart 2013 1 juli 2014 Thetis Pharmaceuticals Llc Tri-salt form of metformin
US8771731 18 aug 2006 8 juli 2014 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US8778922 22 aug 2012 15 juli 2014 Lipocine Inc. Steroidal compositions
US8784869 12 juli 2012 22 juli 2014 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
US8784882 29 juli 2011 22 juli 2014 Mattern Pharma Ag Controlled release delivery system for nasal applications and method of treatment
US8784886 9 maart 2007 22 juli 2014 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
US8802624 18 mei 2011 12 aug 2014 Ferring B.V. Methods of treatment using orodispersible desmopressin pharmaceutical formulations
US8835407 5 juli 2012 16 sept 2014 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
US8853236 30 nov 2012 7 okt 2014 Cydex Pharmaceuticals, Inc. Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
US8865695 26 feb 2014 21 okt 2014 Lipocine Inc. Steroidal compositions
US8877230 10 dec 2011 4 nov 2014 Mattern Pharma Ag Controlled release delivery system for nasal applications
US8901107 21 juni 2013 2 dec 2014 Thetis Pharmaceuticals Llc Lipid-lowering antidiabetic agent
US8933124 16 mei 2014 13 jan 2015 Thetis Pharmaceuticals Llc Tri-salt form of metformin
US8940786 30 sept 2013 27 jan 2015 Teikoku Pharma Usa, Inc. Non-aqueous taxane nanodispersion formulations and methods of using the same
US8987237 6 dec 2013 24 maart 2015 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8987238 6 dec 2013 24 maart 2015 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8993548 3 sept 2014 31 maart 2015 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8993549 3 sept 2014 31 maart 2015 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9006222 6 dec 2013 14 april 2015 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9012434 6 dec 2013 21 april 2015 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9012507 20 dec 2013 21 april 2015 Thetis Pharmaceuticals Llc Lipid-lowering antidiabetic agent
US9034858 31 mei 2012 19 mei 2015 Lipocine Inc. High-strength testosterone undecanoate compositions
US9101574 21 okt 2013 11 aug 2015 Allergan, Inc. Cyclosporin compositions
US9114145 3 sept 2014 25 aug 2015 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9114146 3 sept 2014 25 aug 2015 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9119771 27 juli 2012 1 sept 2015 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US9125945 6 okt 2014 8 sept 2015 Cydex Pharmaceuticals, Inc. Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
US9131680 1 april 2014 15 sept 2015 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US9161902 12 juli 2013 20 okt 2015 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US9173419 29 okt 2013 3 nov 2015 Kemin Industries, Inc. Method of improving animal feeds using hydrolyzed lecithins
US9180090 4 okt 2012 10 nov 2015 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US9186320 30 juli 2011 17 nov 2015 Mattern Pharma Ag Controlled release delivery system for nasal application of neurotransmitters
US9205057 20 april 2015 8 dec 2015 Lipocine Inc. High-strength testosterone undecanoate compositions
US9216951 27 okt 2014 22 dec 2015 Thetis Pharmaceuticals Llc Lipid-lowering antidiabetic agent
US9220747 9 juli 2014 29 dec 2015 Ferring B.V. Methods using desmopressin acetate in orodispersible form
US9238072 2 juli 2014 19 jan 2016 Mattern Pharma Ag Controlled release delivery system for nasal applications and method of treatment
US9242008 1 okt 2014 26 jan 2016 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of fatty acids
US9248130 1 okt 2013 2 feb 2016 Linzy O. Scott, III Methods and compositions for treating thyroid-related medical conditions with reduced folates
US9289382 17 feb 2015 22 maart 2016 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9301920 15 maart 2013 5 april 2016 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9308195 9 dec 2014 12 april 2016 Teikoku Pharma Usa, Inc. Non-aqueous taxane formulations and methods of using the same
US9314505 17 mei 2013 19 april 2016 Otago Innovation Limited Combination treatments and compositions for wound healing comprising viral VEGF
US9339497 29 juli 2015 17 mei 2016 Merrimack Pharmaceuticals, Inc. Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
US9358241 6 juni 2014 7 juni 2016 Lipocine Inc. High-strength testosterone undecanoate compositions
US9364473 3 sept 2015 14 juni 2016 Merrimack Pharmaceuticals, Inc. Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
US9375478 20 mei 2015 28 juni 2016 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375530 15 feb 2013 28 juni 2016 Allergan, Inc. Methods and devices for desmopressin drug delivery
US9382187 10 juli 2013 5 juli 2016 Thetis Pharmaceuticals Llc Tri-salt form of metformin
US9399067 12 sept 2014 26 juli 2016 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
US9421199 29 mei 2015 23 aug 2016 Sydnexis, Inc. Ophthalmic composition
US9452162 12 juni 2013 27 sept 2016 Merrimack Pharmaceuticals, Inc. Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
US9474728 5 sept 2014 25 okt 2016 Tonix Pharma Holdings Limited Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US9480680 6 feb 2014 1 nov 2016 Jingjun Huang Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
US9486408 9 okt 2012 8 nov 2016 University Of Massachusetts Lowell Botulinum nanoemulsions
US9492442 11 sept 2015 15 nov 2016 Merrimack Pharmaceuticals, Inc. Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
US9505709 4 mei 2015 29 nov 2016 Thetis Pharmaceuticals Llc Compositions and methods relating to ionic salts of peptides
US9566306 17 maart 2013 14 feb 2017 Zemtsov Enterprises, Llc Formulations and methods for treatment of wounds and inflammatory skin conditions
US9572818 12 juni 2013 21 feb 2017 Besins Healthcare Luxembourg Sarl Pharmaceutical emulsion compositions comprising progestogen
US9579280 10 dec 2015 28 feb 2017 Mattern Pharma Ag Controlled release delivery system for nasal applications and method of treatment
US9585867 6 aug 2015 7 maart 2017 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US9623045 4 sept 2015 18 april 2017 Cydex Pharmaceuticals, Inc. Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
US9636408 14 maart 2014 2 mei 2017 Tonix Pharma Holdings Limited Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
US9642826 18 mei 2015 9 mei 2017 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US9655873 * 3 maart 2015 23 mei 2017 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US9687526 10 okt 2016 27 juni 2017 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9713616 6 aug 2013 25 juli 2017 Spectrum Pharmaceuticals, Inc. Pharmaceutical compositions comprising L-leucovorin
US9717724 19 aug 2016 1 aug 2017 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies
US9724345 * 13 mei 2016 8 aug 2017 Platform Brightworks Two, Ltd. Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
US9744239 20 mei 2015 29 aug 2017 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785 7 feb 2017 5 sept 2017 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9757388 14 mei 2012 12 sept 2017 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US9757389 26 sept 2016 12 sept 2017 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US9757390 11 april 2017 12 sept 2017 Lipocine Inc. High-strength testosterone undecanoate compositions
US9763880 10 maart 2016 19 sept 2017 Teikoku Pharma Usa, Inc. Non-aqueous taxane formulations and methods of using the same
US9770447 12 juli 2016 26 sept 2017 Sydnexis, Inc. Ophthalmic composition
US9782395 5 mei 2016 10 okt 2017 Minoryx Therapeutics S.L. 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
US9795620 9 dec 2016 24 okt 2017 Dr. Reddy's Laboratories, Ltd. Oral composition of celecoxib for treatment of pain
US9801834 13 okt 2015 31 okt 2017 M et P Pharma AG Controlled release delivery system for nasal application of neurotransmitters
US9801842 9 juni 2014 31 okt 2017 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US20030129243 * 27 dec 2000 10 juli 2003 Bruno Pitard Compositions comprising nucleic acids incorporated in bilaminar mineral particles
US20030147017 * 25 jan 2001 7 aug 2003 Jean-Daniel Bonny Display device with multiple row addressing
US20030236236 * 22 mei 2003 25 dec 2003 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20040017017 * 24 juli 2002 29 jan 2004 Van Lengerich Bernhard H. Encapsulation of sensitive components using pre-emulsification
US20040043041 * 29 dec 2000 4 maart 2004 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US20040092428 * 26 nov 2002 13 mei 2004 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
US20040204343 * 11 april 2003 14 okt 2004 Robert Fishman Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US20050026877 * 10 mei 2004 3 feb 2005 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20050049209 * 20 juli 2004 3 maart 2005 Chen Andrew Xian Pharmaceutical compositions for delivering macrolides
US20050096296 * 23 jan 2004 5 mei 2005 David Fikstad Pharmaceutical compositions with synchronized solubilizer release
US20050096365 * 3 nov 2003 5 mei 2005 David Fikstad Pharmaceutical compositions with synchronized solubilizer release
US20050118194 * 1 dec 2003 2 juni 2005 Sin Yoke M. Oral vaccine, method for its preparation and use thereof
US20050208083 * 28 feb 2005 22 sept 2005 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US20050209172 * 17 maart 2004 22 sept 2005 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US20050226925 * 16 feb 2005 13 okt 2005 Transoral Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20050232997 * 7 mei 2003 20 okt 2005 Ferring B.V. Pharmaceutical formulations
US20050244486 * 26 april 2005 3 nov 2005 Caldwell Larry J Topical methadone compositions and methods for using the same
US20050250738 * 19 april 2005 10 nov 2005 Mosher Gerold L Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin
US20060003002 * 4 mei 2005 5 jan 2006 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US20060008480 * 12 juli 2004 12 jan 2006 Chen Andrew X Compositions for delivering highly water soluble drugs
US20060019921 * 13 juli 2005 26 jan 2006 Haynes Joel R Nucleic acid adjuvants
US20060078577 * 8 okt 2004 13 april 2006 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078579 * 28 feb 2005 13 april 2006 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580 * 13 juni 2005 13 april 2006 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060083783 * 22 april 2005 20 april 2006 Doyle Ralph T Jr Treating metabolic syndrome with fenofibrate
US20060106065 * 15 dec 2005 18 mei 2006 Jacob Gary S Methods of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D- glucuitol compounds in combination therapy
US20060116336 * 13 sept 2005 1 juni 2006 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US20060148903 * 23 nov 2005 6 juli 2006 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
US20060160888 * 9 dec 2005 20 juli 2006 Insys Therapeutics, Inc. Room-temperature stable dronabinol formulations
US20060188527 * 22 okt 2003 24 aug 2006 Hoffman Stephen L Methods for vaccinating against malaria
US20060188529 * 5 dec 2005 24 aug 2006 George Bobotas Stable compositions of fenofibrate with fatty acid esters
US20060211762 * 22 nov 2005 21 sept 2006 Rongen Roelof M Omega-3 fatty acids and dyslipidemic agent for lipid therapy
US20060211763 * 8 maart 2006 21 sept 2006 Abdel Fawzy Treatment with Statin and Omega-3 Fatty Acids and a Combination Product Thereof
US20060229347 * 30 maart 2006 12 okt 2006 Astion Development A/S Treatment of eczemas
US20060264468 * 22 juni 2006 23 nov 2006 United Therapeutics Corporation Use of substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
US20060275358 * 1 juni 2005 7 dec 2006 Cardinal Health Australia 401 Pty. Ltd. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
US20060276501 * 23 mei 2006 7 dec 2006 Transoral Pharmaceuticals, Inc. Solid compositions for treating middle-of-the-night insomnia
US20060281783 * 23 mei 2006 14 dec 2006 Transoral Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070004688 * 6 sept 2006 4 jan 2007 Laidlaw Barbara F Pharmaceutical compositions comprising active vitamin D compounds
US20070015691 * 13 juli 2005 18 jan 2007 Allergan, Inc. Cyclosporin compositions
US20070015692 * 13 juli 2005 18 jan 2007 Chang James N Cyclosporin compositions
US20070054834 * 10 april 2006 8 maart 2007 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
US20070066643 * 23 mei 2006 22 maart 2007 Transoral Pharmaceuticals, Inc. Methods of treating middle-of-the-night insomnia
US20070073688 * 29 sept 2005 29 maart 2007 Fry Jared S Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource
US20070098853 * 31 okt 2005 3 mei 2007 Van Lengerich Bernhard H Encapsulation of readily oxidizable components
US20070098854 * 8 aug 2006 3 mei 2007 Van Lengerich Bernhard H Encapsulation of readily oxidizable components
US20070123562 * 23 mei 2006 31 mei 2007 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the-night insomnia
US20070141096 * 21 feb 2007 21 juni 2007 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
US20070167358 * 11 okt 2006 19 juli 2007 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US20070212411 * 9 maart 2007 13 sept 2007 Abdel Fawzy Coating capsules with active pharmaceutical ingredients
US20070218183 * 14 maart 2006 20 sept 2007 Bunge Oils, Inc. Oil composition of conjugated linoleic acid
US20070225322 * 30 nov 2006 27 sept 2007 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070265207 * 4 mei 2007 15 nov 2007 Fein Seymour H Pharmaceutical Compositions Including Low Dosages of Desmopressin
US20070293703 * 25 juli 2007 20 dec 2007 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
US20080057119 * 3 aug 2007 6 maart 2008 Singh Nikhilesh N Compositions and methods for treating middle-of-the night insomnia
US20080075785 * 29 juni 2007 27 maart 2008 San-Laung Chow Controlled release hydrogel formulation
US20080081067 * 20 aug 2007 3 april 2008 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
US20080098900 * 1 nov 2006 1 mei 2008 Babatunde Aremu Beverage manufacture using a static mixer
US20080112895 * 6 aug 2007 15 mei 2008 Insys Therapeutics Inc. Aqueous dronabinol formulations
US20080181938 * 29 jan 2007 31 juli 2008 Roger Kaspar Methods and compositions for transdermal delivery of nucleotides
US20080274195 * 11 juli 2006 6 nov 2008 University Of Massachusetts Lowell Compositions and Methods for Making and Using Nanoemulsions
US20080274951 * 15 juli 2008 6 nov 2008 Fein Seymour H Pharmaceutical compositions including low dosages of desmopressin
US20090004284 * 26 juni 2007 1 jan 2009 Watson Pharmaceuticals, Inc. Controlled release tamsulosin hydrochloride formulation
US20090005432 * 15 juli 2008 1 jan 2009 Fein Seymour H Pharmaceutical compositions including low dosages of desmopressin
US20090054305 * 15 maart 2007 26 feb 2009 Novo Nordisk A/S Mixtures of Amylin and Insulin
US20090074859 * 2 dec 2008 19 maart 2009 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20090137617 * 24 nov 2008 28 mei 2009 Andrew Levy Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease
US20090143479 * 6 feb 2009 4 juni 2009 Jean-Daniel Bonny Pharmaceutical compositions comprising terbinafine
US20090181080 * 6 aug 2008 16 juli 2009 Insys Therapeutics Inc. Oral cannabinnoid liquid formulations and methods of treatment
US20090181883 * 27 maart 2009 16 juli 2009 Millennium Medical Spa HUMAN CHORIONIC GONADOTROPIN (hCG) FORMULATIONS FOR FACILITATING WEIGHT LOSS AND BODY CONTOURING
US20090264386 * 1 juni 2009 22 okt 2009 Axcan Pharma Inc. Mesalamine suppository
US20090291880 * 21 mei 2009 26 nov 2009 Ferring International Center S.A. Methods comprising desmopressin
US20100021607 * 22 juli 2009 28 jan 2010 Van Lengerich Bernhard H Fruit products containing omega-3 fatty acids
US20100062066 * 8 nov 2007 11 maart 2010 Acusphere, Inc Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
US20100105639 * 16 dec 2009 29 april 2010 Axcan Pharma Inc. Mesalamine suppository
US20100137271 * 24 nov 2009 3 juni 2010 Lipocine, Inc. Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20100150994 * 30 nov 2007 17 juni 2010 Anterios, Inc. Amphiphilic entity nanoparticles
US20100172943 * 30 nov 2007 8 juli 2010 Anterios, Inc. Peptide nanoparticles and uses therefor
US20100240587 * 11 sept 2008 23 sept 2010 Novo Nordisk A/S Stable formulations of amylin and its analogues
US20100249177 * 8 juni 2010 30 sept 2010 Singh Nikhilesh N Compositions and methods for treating middle-of-the-night insomnia
US20100249178 * 9 juni 2010 30 sept 2010 Nikhilesh Singh Compositions and methods for treating middle-of-the-night insomnia
US20100266622 * 28 juni 2010 21 okt 2010 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US20100291004 * 11 maart 2010 18 nov 2010 Singh Nikhilesh N Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20100292268 * 26 april 2008 18 nov 2010 Cydex Pharmaceuticals, Inc. Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
US20100305081 * 13 aug 2010 2 dec 2010 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20100310728 * 4 juni 2010 9 dec 2010 General Mills, Inc. Encapsulated omega-3 fatty acids for baked goods production
US20110004164 * 2 juli 2010 6 jan 2011 Jie Du Non-sedating antihistamine injection formulations and methods of use thereof
US20110008464 * 9 juli 2010 13 jan 2011 Scott Iii Linzy O Methods and compositions for treating thyroid-related medical conditions with reduced folates
US20110039881 * 22 okt 2010 17 feb 2011 Singh Nikhilesh N Compositions and methods for treating middle-of-the-night insomnia
US20110044519 * 5 maart 2009 24 feb 2011 Levasseur Jr Donald P Multi-Function, Foot-Activated Controller for Imaging System
US20110064755 * 23 juli 2010 17 maart 2011 Vical Incorporated Methods for producing block copolymer/amphiphilic particles
US20110082168 * 10 dec 2010 7 april 2011 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US20110086071 * 14 dec 2010 14 april 2011 Jean-Daniel Bonny Pharmaceutical Compositions Comprising Terbinafine
US20110086158 * 17 dec 2010 14 april 2011 Pepsico, Inc. Beverage Manufacture Using a Static Mixer
US20110124656 * 18 nov 2010 26 mei 2011 Tonix Pharmaceuticals, Inc. Methods and Compositions for Treating Symptoms Associated with Post-Traumatic Stress Disorder using Cyclobenzaprine
US20110160168 * 31 dec 2010 30 juni 2011 Differential Drug Development Associates, Llc Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
US20110165236 * 22 feb 2011 7 juli 2011 Biokey, Inc. Controlled release hydrogel formulation
US20110177194 * 14 jan 2011 21 juli 2011 Kemin Industries, Inc. Hydrolyzed Lecithin Product to Improve Digestibility
US20110200657 * 28 april 2011 18 aug 2011 Nanobio Corporation Methods of using nanoemulsion compositions having anti-inflammatory activity
US20110212157 * 26 juni 2009 1 sept 2011 Anterios, Inc. Dermal delivery
US20110223204 * 4 juni 2009 15 sept 2011 Bradford J Duft Treatment of pain with gap junction modulation compounds
US20110262494 * 25 april 2011 27 okt 2011 Besins Healthcare Luxembourg Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
US20110262495 * 25 april 2011 27 okt 2011 Besins Healthcare Luxembourg Sarl Pharmaceutical emulsion compositions comprising progestogen
US20150174092 * 3 maart 2015 25 juni 2015 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
CN101152186B 5 sept 2007 6 juli 2011 杭州平和安康医药科技有限公司 Progesterone injection and method for preparing the same
EP2116618A1 8 mei 2009 11 nov 2009 Agency for Science, Technology And Research Diagnosis and treatment of Kawasaki disease
EP2366787A2 12 jan 2007 21 sept 2011 The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services Codon optimized IL-15 and IL-15R-Alpha genes for expression in mammalian cells
EP2527336A1 24 april 2008 28 nov 2012 Concert Pharmaceuticals Inc. Deuterated analogues of cilostazol
WO2004091498A3 * 8 april 2004 7 april 2005 All Natural Fmg Inc Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
WO2008094866A1 * 28 jan 2008 7 aug 2008 Transderm, Inc. Methods and compositions for transermal delivery of nucleotides
WO2011106705A2 25 feb 2011 1 sept 2011 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Dna-protein vaccination protocols
WO2011123479A1 29 maart 2011 6 okt 2011 Academia Sinica Quantitative measurement of nano / micro particle endocytosis with cell mass spectrometry
WO2013148736A1 26 maart 2013 3 okt 2013 Coda Therapeutics, Inc. Compositions and treatments based on cadherin modulation
WO2014025807A1 * 6 aug 2013 13 feb 2014 Spectrum Pharmaceuticals, Inc. Pharmaceutical compositions comprising l-leucovorin
WO2014124132A1 * 6 feb 2014 14 aug 2014 Jingjun Huang Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
Classificatie in de VS 424/455, 424/450, 424/400, 424/456
Internationale classificatie A61K31/20, A61K9/66, A61K9/107, A61K31/355
Coöperatieve classificatie A61K31/20, A61K31/355, A61K9/1075
Europese classificatie A61K31/20, A61K31/355, A61K9/107D
18 okt 1999 AS Assignment
9 okt 2007 FPAY Fee payment
13 april 2016 LAPS Lapse for failure to pay maintenance fees
31 mei 2016 FP Expired due to failure to pay maintenance fee